Steady state pharmacokinetics and dose-proportionality of phenylpropanolamine in healthy subjects.


The pharmacokinetics of phenylpropanolamine (PPA) were studied in five healthy male volunteers after single oral doses of 25, 50 and 100 mg of the drug as well as at steady state after seven, 4-hourly doses of PPA. The peak serum concentrations and AUC infinity values increased linearly with an increase in dose, whereas the time to reach peak serum… (More)


  • Presentations referencing similar topics